$1.29 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 23 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 29.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPR | Buy | SPIRIT AEROSYSTEMS HLDGS INC | $200,353,000 | -10.0% | 2,749,087 | +1.5% | 15.53% | +19.2% |
| ITRI | Sell | ITRON INC | $155,889,000 | +9.7% | 1,856,921 | -3.3% | 12.08% | +45.3% |
| VST | Sell | VISTRA ENERGY CORP | $135,125,000 | -29.0% | 5,877,562 | -17.5% | 10.47% | -6.0% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $116,982,000 | -12.4% | 551,540 | -30.9% | 9.07% | +16.0% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $91,494,000 | -20.4% | 2,527,456 | -40.1% | 7.09% | +5.4% |
| VG | Buy | VONAGE HLDGS CORP | $89,832,000 | -32.0% | 12,123,131 | +3.7% | 6.96% | -10.0% |
| JCI | Sell | JOHNSON CTLS INTL PLC | $76,328,000 | -50.6% | 1,874,915 | -46.7% | 5.92% | -34.5% |
| CTXS | New | CITRIX SYS INC | $71,128,000 | – | 641,369 | +100.0% | 5.51% | – |
| NXPI | Sell | NXP SEMICONDUCTORS N V | $51,851,000 | -54.3% | 407,438 | -60.8% | 4.02% | -39.5% |
| ZGNX | Sell | ZOGENIX INC | $47,933,000 | -25.1% | 919,484 | -42.5% | 3.72% | -0.8% |
| WBT | Sell | WELBILT INC | $43,453,000 | -60.7% | 2,783,669 | -57.6% | 3.37% | -48.0% |
| UPWK | Sell | UPWORK INC | $40,456,000 | -30.6% | 3,791,520 | -13.5% | 3.14% | -8.1% |
| BA | Sell | BOEING COput | $37,951,000 | -35.6% | 116,500 | -24.8% | 2.94% | -14.8% |
| HHR | Sell | HEADHUNTER GROUP PLCsponsored ads | $31,558,000 | -22.8% | 1,471,241 | -30.6% | 2.45% | +2.2% |
| HLIT | Sell | HARMONIC INC | $30,540,000 | -9.5% | 3,915,387 | -23.7% | 2.37% | +19.8% |
| RTRX | Sell | RETROPHIN INC | $28,566,000 | -23.5% | 2,011,697 | -37.5% | 2.21% | +1.4% |
| HALO | New | HALOZYME THERAPEUTICS INC | $13,111,000 | – | 739,479 | +100.0% | 1.02% | – |
| SPY | New | SPDR S&P 500 ETF TRtr unit | $9,988,000 | – | 31,033 | +100.0% | 0.77% | – |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $6,808,000 | +80.6% | 54,942 | -3.3% | 0.53% | +138.9% |
| PSEC | Sell | PROSPECT CAPITAL CORPORATION | $6,497,000 | -9.2% | 1,008,841 | -7.0% | 0.50% | +20.3% |
| FOSL | Sell | FOSSIL GROUP INC | $3,032,000 | -38.8% | 384,772 | -2.8% | 0.24% | -19.0% |
| MNKD | Sell | MANNKIND CORP | $1,164,000 | -0.3% | 902,277 | -3.4% | 0.09% | +32.4% |
| AMSC | Sell | AMERICAN SUPERCONDUCTOR CORP | $141,000 | -8.4% | 17,945 | -8.5% | 0.01% | +22.2% |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -2,773,777 | -100.0% | -0.47% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -932,333 | -100.0% | -1.13% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -91,200 | -100.0% | -1.58% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -871,780 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.